Development Pipeline

Our strategic roadmap to revolutionize CRISPR therapy design through AI-powered innovation

Key Metrics

>1M
Datasets Processed
>50
Enterprise Trials Simulated
99.7%
Prediction Accuracy
24/7
Platform Availability

MVP & Prototype

Current

Core platform development

Streamlit demo deployed
Basic CRISPR design interface
Core AI algorithms implemented

Pre-clinical Validation

Upcoming

In silico trial simulation

In silico ID of top 5 gRNAs
Off-target prediction models
Efficacy simulation framework

Beta Launch

Upcoming

Closed researcher access

Researcher beta program
API documentation release
Feedback integration system

Commercial Rollout

Future

API SaaS & partnerships

Full platform launch
Enterprise partnerships
Global market expansion

Development Progress

Q1 2026
MVP & Prototype
Q2 2026
Validation Phase
Q3 2026
Beta Launch
Q1 2027
Commercial Rollout

Be part of the next generation of gene therapy innovation

Built with v0